1 / 5

CANCER DE LA VIA BILIAR

ESTADIOS TNM American Joint Committee on Cancer (AJCC). TX El Tumor Primario No pudo ser DetectadoT0 No hay Evidencia de Tumor PrimarioTi0s Carcinoma in situ.T1 Tumor Invade la Membrana Basal o Capa MuscularT1a Tumor Invade la Membrana BasalT1b Tumor Invade la Capa Muscular.

jileen
Download Presentation

CANCER DE LA VIA BILIAR

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. CANCER DE LA VIA BILIAR DR JORGE RAUL ZIMERMAN. PROF. ADJUNTO CATEDRA I CIRUGIA. A / C MATERIA ONCOLOGIA. FACULTAD DE MEDICINA. U. N. N. E.

    2. ESTADIOS TNM American Joint Committee on Cancer (AJCC) TX El Tumor Primario No pudo ser Detectado T0 No hay Evidencia de Tumor Primario Ti0s Carcinoma in situ. T1 Tumor Invade la Membrana Basal o Capa Muscular T1a Tumor Invade la Membrana Basal T1b Tumor Invade la Capa Muscular

    3. ESTADIOS TNM T2 Tumor Invade el Tejido Conjuntivo Peri muscular sin Extensión Más allá de la Serosa o Dentro del Hígado. T3 Tumor Perfora la Serosa o Invade un Órgano T4 Tumor Invade la Vena Porta o Arteria Hepática o Múltiples Órganos Extrahepáticos

    4. TNM NX: NO SE PUEDEN EVALUAR GANGLIOS LINFATICOS REGIONALES NO: NO SE DEMUESTRAN MTTS GANGLIONARES REGIONALES N1 : MTTS EN GANGLIOS DEL CONDUCTO CISTICO PERICOLEDOCIANOS Y/ O HILIARES N2 : MTTS EN GANGLIOS PERIPANCREATICOS (CABEZA) PERIDUODENALES-PERIPORTALES- CELIACOS. MESENTERICOS SUPERIORES

    5. TNM MX: MTTS A DISTANCIA NO PUEDEN SER DETECTADAS M0: NO HAY MTTS A DISTANCIA M1: HAY MTTS A DISTANCIA

    6. BIBLIOGRAFIA Moertel CG, Frytak S, Hahn RG, et al.: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48(8): 1705-1710, 1981. Whittington R, Solin L, Mohiuddin M, et al.: Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 54(9): 1991-1998, 1984. Moertel CG, Childs DS, Reitemeier RJ, et al.: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2(7626): 865-867, 1969. Tepper JE, Noyes D, Krall JM, et al.: Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. International Journal of Radiation Oncology, Biology, Physics 21(5): 1145-1149, 1991. Kalser MH, Ellenberg SS: Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Archives of Surgery 120(8): 899-903, 1985. Polati E, Finco G, Gottin L, et al.: Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. British Journal of Surgery 85(2): 199-201, 1998. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59(12): 2006-2010, 1987. van den Bosch RP, van der Schelling GP, Klinkenbijl JH, et al.: Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Annals of Surgery 219(1): 18-24, 1994. Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. New

More Related